Oprah winfrey attends paris fashion week with gayle king

oprah winfrey — US news

Oprah Winfrey and Gayle King at Paris Fashion Week

Oprah Winfrey and Gayle King attended the Chloé show during Paris Fashion Week on March 5, 2026. The two friends, known for their long-standing relationship and frequent appearances together, showcased their fashion sense by wearing snake-effect Chloé Cleia pumps. Oprah opted for a darker beige version, while Gayle chose a lighter off-white pair. The Cleia pumps feature a T-bar construction and a 70 mm curved stiletto heel.

Weight Loss Medication Confirmation

During the event, Oprah Winfrey confirmed that she takes weight loss medication, although she did not specify if it is Ozempic. This revelation follows her earlier statements in January 2025, where she mentioned using a GLP-1 agonist, a category that includes Ozempic. Oprah has stated that she utilizes weight loss medication as a tool to manage her weight, emphasizing her desire to avoid the yo-yo dieting cycle.

In 2023, Oprah first acknowledged taking weight loss medication but did not disclose the specific type. Her recent comments have led to public speculation about her health and the medication she is using. Social media reactions have included concerns, with one anonymous user questioning, “What in the Ozempic Oprah is going on here?” Another expressed worry for her well-being, stating, “I’m afraid Oprah may OD on Ozempic. Welfare check, please!”

Public Response and Future Implications

Oprah’s openness about her weight management journey has sparked a mix of reactions. She has expressed that she now uses the medication as needed, saying, “I now use it as I feel I need it, as a tool to manage not yo-yoing. It quiets the food noise.” However, she also reflected on her internal struggles, stating, “There’s a part of me that feels … I’ve got to do it the hard way. I’ve got to keep climbing the mountains. I’ve got to keep suffering. I’ve got to do that because otherwise I somehow cheated myself.”

Details remain unconfirmed regarding whether Oprah is specifically taking Ozempic or another GLP-1 agonist. The health concerns raised by the public regarding Oprah’s appearance are also not confirmed. Observers will be watching closely to see how this situation develops and what further statements may come from Oprah or her representatives.